First Horizon Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Buy |
2,281
+699
| +44% | +$54.8K | 0.01% | 524 |
|
|
2025
Q1 | $108K | Buy |
1,582
+320
| +25% | +$26.1K | ﹤0.01% | 663 |
|
|
2024
Q4 | $98.1K | Sell |
1,262
-294
| -19% | -$21.8K | ﹤0.01% | 700 |
|
|
2024
Q3 | $104K | Buy |
1,556
+89
| +6% | +$7.31K | ﹤0.01% | 708 |
|
|
2024
Q2 | $166K | Buy |
1,467
+465
| +46% | +$58.8K | 0.01% | 551 |
|
|
2024
Q1 | $139K | Buy |
1,002
+55
| +6% | +$6.91K | ﹤0.01% | 599 |
|
|
2023
Q4 | $118K | Buy |
947
+41
| +5% | +$4.19K | ﹤0.01% | 618 |
|
|
2023
Q3 | $84.5K | Buy |
906
+46
| +5% | +$5.18K | ﹤0.01% | 675 |
|
|
2023
Q2 | $111K | Sell |
860
-50
| -5% | -$6.05K | ﹤0.01% | 617 |
|
|
2023
Q1 | $106K | Sell |
910
-50
| -5% | -$5.6K | ﹤0.01% | 625 |
|
|
2022
Q4 | $109K | Buy |
960
+86
| +10% | +$9.44K | ﹤0.01% | 593 |
|
|
2022
Q3 | $69K | Buy |
874
+23
| +3% | +$1.95K | ﹤0.01% | 726 |
|
|
2022
Q2 | $62K | Buy |
851
+559
| +191% | +$51K | ﹤0.01% | 855 |
|
|
2022
Q1 | $37K | Sell |
292
-580
| -67% | -$63.4K | ﹤0.01% | 714 |
|
|
2021
Q4 | $116K | Sell |
872
-76
| -8% | -$10.9K | ﹤0.01% | 637 |
|
|
2021
Q3 | $128K | Buy |
948
+120
| +14% | +$15.1K | ﹤0.01% | 602 |
|
|
2021
Q2 | $88K | Buy |
828
+184
| +29% | +$17.7K | ﹤0.01% | 578 |
|
|
2021
Q1 | $57K | Buy |
+644
| New | +$60.5K | ﹤0.01% | 686 |
|
|
2020
Q4 | – | Sell |
-44
| Closed | -$4K | – | 1476 |
|
|
2020
Q3 | $4K | Sell |
44
-20
| -31% | -$2.09K | ﹤0.01% | 1202 |
|
|
2020
Q2 | $6K | Sell |
64
-32
| -33% | -$2.86K | ﹤0.01% | 1127 |
|
|
2020
Q1 | $6K | Buy |
+96
| New | +$5.97K | ﹤0.01% | 1065 |
|
|
2017
Q4 | – | Sell |
-1,120
| Closed | -$13K | – | 1447 |
|
|
2017
Q3 | $13K | Hold |
1,120
| – | – | ﹤0.01% | 909 |
|
|
2017
Q2 | $19K | Sell |
1,120
-14,000
| -93% | -$259K | ﹤0.01% | 802 |
|
|
2017
Q1 | $318K | Hold |
15,120
| – | – | 0.04% | 261 |
|
|
2016
Q4 | $329K | Hold |
15,120
| – | – | 0.04% | 253 |
|
|
2016
Q3 | $329K | Hold |
15,120
| – | – | 0.04% | 249 |
|
|
2016
Q2 | $299K | Hold |
15,120
| – | – | 0.04% | 245 |
|
|
2016
Q1 | $255K | Buy |
15,120
+208
| +1% | +$3.48K | 0.03% | 287 |
|
|
2015
Q4 | $305K | Buy |
14,912
+13,584
| +1,023% | +$283K | 0.05% | 223 |
|
|
2015
Q3 | $28K | Hold |
1,328
| – | – | ﹤0.01% | 683 |
|
|
2015
Q2 | $26K | Buy |
1,328
+48
| +4% | +$843 | ﹤0.01% | 756 |
|
|
2015
Q1 | $19K | Hold |
1,280
| – | – | ﹤0.01% | 856 |
|
|
2014
Q4 | $17K | Hold |
1,280
| – | – | ﹤0.01% | 874 |
|
|
2014
Q3 | $12K | Buy |
+1,280
| New | +$13.1K | ﹤0.01% | 1011 |
|
Other funds holding DXCM
N
First Horizon Advisors's DXCM Position: Q2 2025 in Review
First Horizon Advisors increased its DexCom (DXCM) stake by 44% in Q2 2025, buying an estimated $54.8K and bringing the position to 2,281 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #524.
First Horizon Advisors first reported a position in DXCM in Q3 2014 and has held it in 34 quarters since. The position peaked at $329K in Q4 2016. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.
- First Horizon Advisors held 2,281 shares of DexCom worth $199K as of Q2 2025.
- First Horizon Advisors bought 699 DexCom shares in Q2 2025, an estimated $54.8K.
- DexCom made up 0.01% of First Horizon Advisors's portfolio in Q2 2025, its #524 holding.
- First Horizon Advisors first reported a position in DexCom in Q3 2014 and has held it in 34 quarters since.
- First Horizon Advisors's DexCom position peaked at $329K in Q4 2016.
- 940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.